1. Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018 Jun 1;96(6):414-422D. doi: 10.2471/BLT.17.206441. Epub 2018 Apr 20. PMID: 29904224; PMCID: PMC5996218.
2. Jha V, Al-Ghamdi SMG, Li G, Wu MS, Stafylas P, Retat L, Card-Gowers J, Barone S, Cabrera C, Garcia Sanchez JJ. Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme. Adv Ther. 2023 Oct;40(10):4405-4420. doi: 10.1007/s12325-023-02608-9. Epub 2023 Jul 26. PMID: 37493856; PMCID: PMC10499937.
3. Ommati MM, Amjadinia A, Mousavi K, Azarpira N, Jamshidzadeh A, Heidari R. N-acetyl cysteine treatment mitigates biomarkers of oxidative stress in different tissues of bile duct ligated rats. Stress. 2021 Mar;24(2):213-228. doi: 10.1080/10253890.2020.1777970. Epub 2020 Jun 22. PMID: 32510264.
4. Abdoli N, Sadeghian I, Mousavi K, Azarpira N, Ommati MM, Heidari R. Suppression of cirrhosis-related renal injury by N-acetyl cysteine. Curr Res Pharmacol Drug Discov. 2020 Oct 13;1:30-38. doi: 10.1016/j.crphar.2020.100006. PMID: 34909640; PMCID: PMC8663932.
5. Stolf AM, Cardoso CC, Acco A. Effects of Silymarin on Diabetes Mellitus Complications: A Review. Phytother Res. 2017 Mar;31(3):366-374. doi: 10.1002/ptr.5768. Epub 2017 Jan 25. PMID: 28124457.
6. Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M. Targeting Free Radicals in Oxidative Stress-Related Human Diseases. Trends Pharmacol Sci. 2017 Jul;38(7):592-607. doi: 10.1016/j.tips.2017.04.005. Epub 2017 May 24. PMID: 28551354.
7. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol. 2004 Oct;287(4):C817-33. doi: 10.1152/ajpcell.00139.2004. PMID: 15355853.
8. Ommati MM, Heidari R, Ghanbarinejad V, Aminian A, Abdoli N, Niknahad H. The neuroprotective properties of carnosine in a mouse model of manganism is mediated via mitochondria regulating and antioxidative mechanisms. Nutr Neurosci. 2020 Sep;23(9):731-743. doi: 10.1080/1028415X.2018.1552399. Epub 2019 Mar 11. PMID: 30856059.
9. Heidari R. The footprints of mitochondrial impairment and cellular energy crisis in the pathogenesis of xenobiotics-induced nephrotoxicity, serum electrolytes imbalance, and Fanconi's syndrome: A comprehensive review. Toxicology. 2019 Jul 1;423:1-31. doi: 10.1016/j.tox.2019.05.002. Epub 2019 May 13. PMID: 31095988.
10. Tang C, Dong Z. Mitochondria in Kidney Injury: When the Power Plant Fails. J Am Soc Nephrol. 2016 Jul;27(7):1869-72. doi: 10.1681/ASN.2015111277. Epub 2016 Jan 7. PMID: 26744487; PMCID: PMC4926990.
11. Niknahad AM, Ommati MM, Farshad O, Moezi L, Heidari R. Manganese-induced nephrotoxicity is mediated through oxidative stress and mitochondrial impairment. J Renal Hepatic Disorder. 2020;4(2);1-10. doi: 10.15586/jrenhep.2020.66.
12. Cherla G, Jaimes EA. Role of L-arginine in the pathogenesis and treatment of renal disease. J Nutr. 2004 Oct;134(10 Suppl):2801S-2806S; discussion 2818S-2819S. doi: 10.1093/jn/134.10.2801S. PMID: 15465789.
13. Morris CR, Brown LAS, Reynolds M, Dampier CD, Lane PA, Watt A, et al. Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain. Blood. 2020 Sep 17;136(12):1402-1406. doi: 10.1182/blood.2019003672. PMID: 32384147; PMCID: PMC7498366.
14. Cherian L, Chacko G, Goodman C, Robertson CS. Neuroprotective effects of L-arginine administration after cortical impact injury in rats: dose response and time window. J Pharmacol Exp Ther. 2003 Feb;304(2):617-23. doi: 10.1124/jpet.102.043430. PMID: 12538814.
15. Hirfanoglu I, Turkyilmaz C, Turkyilmaz Z, Onal E, Soylemezoglu F, Karabulut R, et al. Neuroprotective effect of L-arginine in a neonatal rat model of hypoxic-ischemia. Int J Neurosci. 2019 Nov;129(11):1139-1144. doi: 10.1080/00207454.2019.1636794. Epub 2019 Jul 9. PMID: 31234674.
16. Barros CDS, Livramento JB, Mouro MG, Higa EMS, Moraes CT, Tengan CH. L-Arginine Reduces Nitro-Oxidative Stress in Cultured Cells with Mitochondrial Deficiency. Nutrients. 2021 Feb 6;13(2):534. doi: 10.3390/nu13020534. PMID: 33562042; PMCID: PMC7914615.
17. Zhang H, Liu X, Fan Y, Yu Y, Loor JJ, Elsabagh M, et al. l-Arginine Alleviates Hydrogen Peroxide-Induced Oxidative Damage in Ovine Intestinal Epithelial Cells by Regulating Apoptosis, Mitochondrial Function, and Autophagy. J Nutr. 2021 Apr 8;151(4):1038-1046. doi: 10.1093/jn/nxaa428. PMID: 33693729.
18. Klahr S. The role of nitric oxide in hypertension and renal disease progression. Nephrol Dial Transplant. 2001;16 Suppl 1:60-2. doi: 10.1093/ndt/16.suppl_1.60. PMID: 11369823.
19. Saleh S, El-Demerdash E. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide. Basic Clin Pharmacol Toxicol. 2005 Aug;97(2):91-7. doi: 10.1111/j.1742-7843.2005.pto_114.x. PMID: 15998355.
20. Elbassuoni EA, Ragy MM, Ahmed SM. Evidence of the protective effect of l-arginine and vitamin D against monosodium glutamate-induced liver and kidney dysfunction in rats. Biomed Pharmacother. 2018 Dec;108:799-808. doi: 10.1016/j.biopha.2018.09.093. Epub 2018 Sep 22. PMID: 30253372.
21. Hesketh EE, Vernon MA, Ding P, Clay S, Borthwick G, Conway B, Hughes J. A murine model of irreversible and reversible unilateral ureteric obstruction. J Vis Exp. 2014 Dec 20;(94):52559. doi: 10.3791/52559. PMID: 25549273; PMCID: PMC4396952.
22. Saad EA. Curative and protective effects of L-arginine on carbon tetrachloride-induced hepatotoxicity in mice. Biochem Biophys Res Commun. 2012 Jun 22;423(1):147-51. doi: 10.1016/j.bbrc.2012.05.102. Epub 2012 May 24. PMID: 22634310.
23. Heidari R, Niknahad H. The Role and Study of Mitochondrial Impairment and Oxidative Stress in Cholestasis. Methods Mol Biol. 2019;1981:117-132. doi: 10.1007/978-1-4939-9420-5_8. PMID: 31016651.
24. Heidari R, Ommati MM, Niknahad H. Methods for measuring brain mitochondrial impairment and oxidative stress in hepatic encephalopathy. In: Balzano T, editor. Experimental and Clinical Methods in Hepatic Encephalopathy Research. New York, NY: Springer US; 2025. p. 293-313.
25. Heidari R, Jamshidzadeh A, Ghanbarinejad V, Ommati MM, Niknahad H. Taurine supplementation abates cirrhosis-associated locomotor dysfunction. Clin Exp Hepatol. 2018 Jun;4(2):72-82. doi: 10.5114/ceh.2018.75956. Epub 2018 May 25. PMID: 29904723; PMCID: PMC6000746.
26. Heidari R, Babaei H, Eghbal MA. Amodiaquine-induced toxicity in isolated rat hepatocytes and the cytoprotective effects of taurine and/or N-acetyl cysteine. Res Pharm Sci. 2014 Mar-Apr;9(2):97-105. PMID: 25657778; PMCID: PMC4311296.
27. Ahmadi A, Niknahad H, Li H, Mobasheri A, Manthari RK, Azarpira N, et al. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity. Toxicol Lett. 2021 Oct 1;349:12-29. doi: 10.1016/j.toxlet.2021.05.012. Epub 2021 Jun 2. Erratum in: Toxicol Lett. 2022 Jan 1;354:65. doi: 10.1016/j.toxlet.2021.07.006. PMID: 34089816.
28. Shafiekhani M, Ommati MM, Azarpira N, Heidari R, Salarian AA. Glycine supplementation mitigates lead-induced renal injury in mice. J Exp Pharmacol. 2019 Feb 18;11:15-22. doi: 10.2147/JEP.S190846. PMID: 30858736; PMCID: PMC6385776.
29. Heidari R, Moezi L, Asadi B, Ommati MM, Azarpira N. Hepatoprotective effect of boldine in a bile duct ligated rat model of cholestasis/cirrhosis. PharmaNutrition. 2017;5(3);109-17. doi: 10.1016/j.phanu.2017.07.001.
30. Siavashpour A, Khalvati B, Azarpira N, Mohammadi H, Niknahad H, Heidari R. Poly (ADP-Ribose) polymerase-1 (PARP-1) overactivity plays a pathogenic role in bile acids-induced nephrotoxicity in cholestatic rats. Toxicol Lett. 2020 May 16;330:144-158. doi: 10.1016/j.toxlet.2020.05.012. Epub ahead of print. PMID: 32422328.
31. Heidari R, Rasti M, Shirazi Yeganeh B, Niknahad H, Saeedi A, Najibi A. Sulfasalazine-induced renal and hepatic injury in rats and the protective role of taurine. Bioimpacts. 2016;6(1):3-8. doi: 10.15171/bi.2016.01. Epub 2016 Mar 28. PMID: 27340618; PMCID: PMC4916549.
32. Heidari R, Taheri V, Rahimi HR, Shirazi Yeganeh B, Niknahad H, Najibi A. Sulfasalazine-induced renal injury in rats and the protective role of thiol-reductants. Ren Fail. 2016;38(1):137-41. doi: 10.3109/0886022X.2015.1096731. Epub 2015 Oct 19. PMID: 26479898.
33. Li W, Lu Y, Lou Y, Zhao S, Cui W, Wang Y, et al. FFNT25 ameliorates unilateral ureteral obstruction-induced renal fibrosis. Ren Fail. 2019 Nov;41(1):419-426. doi: 10.1080/0886022X.2019.1612430. PMID: 31140898; PMCID: PMC6566665.
34. Rezaei H, Honarpishefard Z, Ghaderi F, Rouhani A, Jamshidzadeh A, Kashani SMA, et al. Mitochondrial impairment and oxidative stress are essential mechanisms involved in the pathogenesis of acute kidney injury. J Renal Hepatic Disorder. 2023;7(2);30-45. doi: 10.15586/jrenhep.v7i2.94.
35. Piko N, Bevc S, Hojs R, Ekart R. The Role of Oxidative Stress in Kidney Injury. Antioxidants (Basel). 2023 Sep 16;12(9):1772. doi: 10.3390/antiox12091772. PMID: 37760075; PMCID: PMC10525550.
36. Dendooven A, Ishola DA Jr, Nguyen TQ, Van der Giezen DM, Kok RJ, Goldschmeding R, et al. Oxidative stress in obstructive nephropathy. Int J Exp Pathol. 2011 Jun;92(3):202-10. doi: 10.1111/j.1365-2613.2010.00730.x. Epub 2010 Aug 27. PMID: 20804541; PMCID: PMC3101492.
37. Yin WH, Chen JW, Tsai C, Chiang MC, Young MS, Lin SJ. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin Nutr. 2005 Dec;24(6):988-97. doi: 10.1016/j.clnu.2005.07.003. Epub 2005 Sep 6. PMID: 16140428.
38. Suschek CV, Schnorr O, Hemmrich K, Aust O, Klotz LO, Sies H, Kolb-Bachofen V. Critical role of L-arginine in endothelial cell survival during oxidative stress. Circulation. 2003 May 27;107(20):2607-14. doi: 10.1161/01.CIR.0000066909.13953.F1. Epub 2003 May 12. PMID: 12742995.
39. Böger RH. The pharmacodynamics of L-arginine. J Nutr. 2007 Jun;137(6 Suppl 2):1650S-1655S. doi: 10.1093/jn/137.6.1650S. PMID: 17513442.
40. Wu G, Meininger CJ. Arginine nutrition and cardiovascular function. J Nutr. 2000 Nov;130(11):2626-9. doi: 10.1093/jn/130.11.2626. PMID: 11053497.
41. Liang M, Wang Z, Li H, Cai L, Pan J, He H, et al. l-Arginine induces antioxidant response to prevent oxidative stress via stimulation of glutathione synthesis and activation of Nrf2 pathway. Food Chem Toxicol. 2018 May;115:315-328. doi: 10.1016/j.fct.2018.03.029. Epub 2018 Mar 22. PMID: 29577948.
42. Che R, Yuan Y, Huang S, Zhang A. Mitochondrial dysfunction in the pathophysiology of renal diseases. Am J Physiol Renal Physiol. 2014 Feb 15;306(4):F367-78. doi: 10.1152/ajprenal.00571.2013. Epub 2013 Dec 4. PMID: 24305473.
43. Blagov AV, Orekhova VA, Zhuravlev AD, Yakovlev AA, Sukhorukov VN, Orekhov AN. Development of mitochondrial dysfunction and oxidative stress in chronic kidney disease. Eur J Inflamm. 2024;22(1721727X241227349. doi: 10.1177/1721727X241227349.
44. Ishimoto Y, Inagi R. Mitochondria: a therapeutic target in acute kidney injury. Nephrol Dial Transplant. 2016 Jul;31(7):1062-9. doi: 10.1093/ndt/gfv317. Epub 2015 Sep 1. PMID: 26333547.
45. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, et al. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med. 2008 Jul 1;45(1):18-31. doi: 10.1016/j.freeradbiomed.2008.03.020. Epub 2008 Apr 4. PMID: 18439435; PMCID: PMC2572721.
46. Nakamura T, Lipton SA. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases. Antioxid Redox Signal. 2008 Jan;10(1):87-101. doi: 10.1089/ars.2007.1858. PMID: 17961071.
47. Li Q, Liu Y, Che Z, Zhu H, Meng G, Hou Y, et al. Dietary L-arginine supplementation alleviates liver injury caused by Escherichia coli LPS in weaned pigs. Innate Immun. 2012 Dec;18(6):804-14. doi: 10.1177/1753425912441955. Epub 2012 Mar 22. PMID: 22441699.
48. Kurokawa T, An J, Tsunekawa K, Shimomura Y, Kazama S, Ishikawa N, et al. Effect of L-arginine supplement on liver regeneration after partial hepatectomy in rats. World J Surg Oncol. 2012 May 31;10:99. doi: 10.1186/1477-7819-10-99. PMID: 22651848; PMCID: PMC3449194.